| Identification | Back Directory | [Name]
3-Azetidinol, 1-[3-(2-benzo[b]thien-5-ylethoxy)propyl]-, (2Z)-2-butenedioate (1:1) | [CAS]
519187-97-4 | [Synonyms]
Edonerpic
T-817MA))
T-817 maleate
CAS#519187-23-6
Edonerpic maleate
Edonerpic maleate (T-817 maleate
T-817; T 817; T817; CAS#519187-23-6; EDONERPIC; EDONERPIC MALEATE
3-Azetidinol, 1-[3-(2-benzo[b]thien-5-ylethoxy)propyl]-, (2Z)-2-butenedioate (1:1) | [Molecular Formula]
C20H25NO6S | [MDL Number]
MFCD13152397 | [MOL File]
519187-97-4.mol | [Molecular Weight]
407.481 |
| Chemical Properties | Back Directory | [storage temp. ]
Store at -20°C | [solubility ]
DMSO:90.5(Max Conc. mg/mL);222.1(Max Conc. mM)
Ethanol:40.0(Max Conc. mg/mL);98.16(Max Conc. mM)
Water:90.5(Max Conc. mg/mL);222.1(Max Conc. mM) | [form ]
A solid | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
3-Azetidinol, 1-[3-(2-benzo[b]thien-5-ylethoxy)propyl]-, (2Z)-2-butenedioate (1:1) can be used as organic synthesis intermediates and pharmaceutical intermediates, mainly used in laboratory research and development process and chemical production process. | [in vivo]
The post hoc test indicates that the mean density of PSA-positive cells is significantly larger in the vehicle and Aβ infusion+high-dose Edonerpic maleate (T-817MA) groups than that in the Aβ infusion control group (P<0.01). The results indicate that the vehicle and Aβ infusion+high-dose Edonerpic maleate groups display efficient learning in the place learning task (PLT), while these two groups also display vigorous neurogenesis. Treatment with Edonerpic maleate and donepezil does not increase the mean density of normal granule cells; there are no significant differences in the mean granule cell density among the Aβ infusion control, Aβ infusion+high-dose Edonerpic maleate, Aβ infusion+low-dose Edonerpic maleate and Aβ infusion+donepezil groups[2]. | [storage]
Store at -20°C |
|
|